Sequence Bio

Putting NL First

Sequence Bio is a locally owned and operated genetics research company committed to Newfoundland and Labrador. Genetic research is a huge opportunity for this province, and that’s why our approach puts Newfoundland and Labrador first every step of the way.

Building a brighter future

  • Sequence Bio has already contributed an estimated $10 million to the provincial economy.
  • We are committed to creating over 100 new jobs and investing $150 million in the local economy by growing the local biotechnology sector.

A local team

  • Sequence Bio is headquartered in St. John’s and employs over 25 highly skilled individuals, many of which are in the emerging Science, Technology, Engineering and Mathematics (STEM) fields.
  • Our team is full of proud graduates of Memorial University, in addition to awesome co-op and PhD students.

Key partners

  • The Provincial Government of Newfoundland and Labrador owns a part of Sequence Bio through an investment in the company.
  • In collaboration with Sequence Bio, Memorial University will be compensated for discoveries made using any of their existing data through a Master Licensing Agreement.

Free access to genetic information and genetic counselling support

  • Information from our research will stay in Newfoundland and Labrador and be shared with participants, their physicians and the province for free.
  • Participants can choose whether they want to receive genetic findings that may help guide treatment options and outcomes.
  • Genetic counselling support will be provided at no cost to participants and their doctors by Sequence Bio.

Improving healthcare delivery

  • By providing cutting edge genomic information to the province for free, Sequence Bio wants to put Newfoundland and Labrador on the forefront of genomic healthcare and save the Provincial Government costly expenditures in the future.
  • Free education, training and genetic counselling support to physicians on how to use genetic findings in the treatment and care of patients.

Our community

  • Sequence Bio won the St. John’s Board of Trade Business Excellence and Community Impact (under 20 employees) awards in 2017, demonstrating our ongoing commitment to the community and local economy.
  • Working to train and develop new students in genomics, bioinformatics, statistics and technology.

St. John’s based biotechnology company Sequence Bio is leading the NL Genome Project.

Sequence Bio’s Chief Strategy Officer, Richard A. Leach, PhD is the Principal Investigator of the study. Sequence Bio’s Director of Research, Gerald Mugford, PhD, and Dr. Dennis O’Keefe are the Co-Principal Investigators.

Questions about your rights as a participant in a research study?

Contact the HREA Ethics Office. They are not involved with running the study.

(709) 777-6974|

Privacy policy